Back

Risk Assessment in Patients with Symptomatic and Asymptomatic Preexcitation (RASAP)

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 5 Invasive Diagnostic Methods EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Serkan Saygi

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Findings at repeat ablation after complex left atrial pulsed field ablation for longstanding persistent atrial fibrillation
Associate Professor M. Fiala (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation
Miss K. Toller (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Changes in local endocardial electrograms immediately after PFA show dose-dependent variations
Doctor G. Amoros-Figueras (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Role of mechanical circulatory support in VT ablation procedures: data from the German PROTECT VT registry
Professor R. Wakili (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Implementation of nurse administered propofol sedation for same-day discharge pulsed field ablation of atrial fibrillation is safe and has excellent patient reviews.
Mrs C. Gybel (Odense, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 5

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Prophylactic catheter ablation in asymptomatic adult and pediatric patients with wolff-parkinson-white pattern: a systematic review and meta-analysis.
thumbnail
Congress Presentation
Wolff-Parkinson-White syndrome in a young athlete: a comprehensive intervention does not end with successful ablation
thumbnail
Congress Presentation
Comprehensive electrophysiological study including ajmaline challenge to guide pacemaker implantation after transcatheter aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources